Qingdao Baheal Medical INC. (301015) — Capital Reinvestment Ratio
Qingdao Baheal Medical INC. (301015) has a Capital Reinvestment Ratio of 0.47x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥230.38 Million) in capital expenditures (CN¥107.50 Million). See debt-free asset ratio of Qingdao Baheal Medical INC. to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Qingdao Baheal Medical INC. Capital Reinvestment Ratio (2018–2025)
This chart tracks Qingdao Baheal Medical INC.'s Capital Reinvestment Ratio across 7 annual periods. Check Qingdao Baheal Medical INC. (301015) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Qingdao Baheal Medical INC. (2018–2025)
Year-by-year Capital Reinvestment Ratio for Qingdao Baheal Medical INC. from 2018 to 2025. For live market cap and broader valuation context, see how much is Qingdao Baheal Medical INC. worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | CN¥934.45 Million | CN¥288.93 Million | ▼ -17.2% |
| 2024 | 0.37x | CN¥813.85 Million | CN¥303.99 Million | ▲ +61.0% |
| 2023 | 0.23x | CN¥799.50 Million | CN¥185.49 Million | ▼ -32.6% |
| 2022 | 0.34x | CN¥305.75 Million | CN¥105.32 Million | ▲ +127.2% |
| 2021 | 0.15x | CN¥181.30 Million | CN¥27.49 Million | ▲ +135.9% |
| 2019 | 0.06x | CN¥45.96 Million | CN¥2.95 Million | ▼ -77.3% |
| 2018 | 0.28x | CN¥55.50 Million | CN¥15.74 Million | — |